• head_banner_01

ئاقسىلنى بىرىكتۈرۈش ئۈچۈن ئىشلىتىلىدىغان ئامىنو كىسلاتاسىنىڭ غەلبىسى

قىسقا چۈشەندۈرۈش:

NO

مەھسۇلاتلار

Cas no

1

Fmoc-d-Ala-D-Ala-Ala-AH

NA

2

Fmoc-β-ALA-D-ALA-ALA-AH

NA

3

Fmoc-arg (PBF) -arg (PBF) -oh

NA


مەھسۇلات تەپسىلاتى

مەھسۇلات خەتكۈچلىرى

مەھسۇلات تەپسىلاتى

NO

مەھسۇلاتلار

Cas no

ئاچقۇچلۇق سۈپەت كۆرسەتكۈچى

Purity

Max.

effurity

ئومۇمىي ھەل قىلىش پۇرسىتى

نەملىك

1

FMOC-β-ALA-ALA-AHA

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

2

Fmoc-d-Ala-D-Ala-Ala-AH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

3

Fmoc-β-ALA-D-ALA-ALA-AH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

4

Fmoc-arg (PBF) -arg (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

5

FMOC-β-ALA-ALG (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

6

Fmoc-d-arg (PBF) -D-ARG (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

7

FMOC-β-ALA-D-D-ARG (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

8

FMOC-HOMOARG (PBF) ---وزگ (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

9

FMOC-β-ALA-ALAARG (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

10

Fmoc-asn (TRT) -ھەن (TRA) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

11

FMOC-β-Ala-ASN (TRT) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

12

FMOC-asp (OTBU) -ASP (OTBU) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

13

FMOC-β-ALA-ALA-ASP (OTBU) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

14

FMoc-cys (TRT) -و (TRT )--

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

15

FMOC-β-ALA-CYS (TRT) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

16

FMOC-CYS (ACM) -

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

17

FMOC-β-ALA-CYS (ACM) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

18

Fmoc-gln (TRT) -Gln (TRT) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

19

FMOC-β-ALA-GLN (TRT) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

20

FMOC-Glu (OTBU)-تىزىملىك ​​(OTBU) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

21

FMOC-β-ALA-GLU (OTBU) -oh.h2o

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

22

Fmoc-β-ALA-Gly-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

23

Fmoc-his (tranclin) -his (TRT) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

24

FMOC-β-ALA-ALA (TRT )-

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

25

Fmoc-ile-ile-ile-ih

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

26

FMOC-β-ALA-ILE-IY-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

27

Fmoc-leu-leu-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

28

Fmoc-β-ALA-leu-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

29

Fmoc-d-leu-d-leu-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

30

Fmoc-β-ALA-D-leu-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

31

FMOC-Lys (BOC) -lys (boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

32

FMOC-β-ALA-LYS (BOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

33

FMOC-Lys (alcloc) -lys -ly (alcloc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

34

Fmoc-β-ALA-LYS (alcloc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

35

Fmoc-mets nown-hange-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

36

FMOC-β-ALA-ALA-ALA-AH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

37

FMOC-orn (boc)--ور (بوكو) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

38

FMOC-β-ALA-orn (Boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

39

Fmoc-phe-phe-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

40

Fmoc-β-ALA-PHE-AH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

41

Fmoc-d-phe-d-phe-a-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

42

Fmoc-β-ALA-D-D-Phe-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

43

Fmoc-pro-pro-ah

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

44

Fmoc-β-ALA-ALA-AL-AH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

45

FMOC-SEAR (TBU) --TBU (TBU )-h

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

46

FMOC-β-ALA-ALA-ALA (TBU )-h

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

47

FMOC-SE (TRA) --- "

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

48

FMOC-β Ala-Ala (TRT) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

49

Fmoc-thr (tbu)---hr (TBU)--oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

50

FMOC-β-ALA-THR (TBU) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

51

FMOC-TRP (BOC) -RP (BOC )-h

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

52

Fmoc-β-ALA-TRP (BOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

53

FMOC-D-TRP (BOC) -D-Tr-Trp (boc) -o

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

54

Fmoc-β-ALA-D-D-TRP (BOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

55

FMOC-TYR (TBU)---قۇنە (TBU) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

56

FMOC-β-ALA-TYR (TBU) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

57

FMOC-D-Tyr (ET) (ET) -D-ALR (ETS) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

58

FMOC-β-ALA-D-D-Tyr (ET) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

59

FMOC-TYR (ME)----مەن (مەن) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

60

FMOC-β-ALA-TYR (ME) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

61

Fmoc-val-val-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

62

Fmoc-β-ALA-ALA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

63

Fmoc-d-cit-d-cit-fit-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

64

FMOC-β-ALA-D-cit-fit-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

65

Fmoc-β-ALA-DAB-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

66

FMOC- ((3- (2-نافېل)-ALA) 2-ALA

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

67

Fmoc-β-ALA-3- (2-nohthyl)-ALA-ALA-AHA

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

68

Fmoc- ((3- (3- PYRIDINYL)-ALA (AD-ALA) 2-ئاھ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

69

Fmoc-β-ALA-3- (3-PYRIDINYL)-ALA-ALA-AH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

70

Fmoc- (4-خلورو-D-Phe) 2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

71

Fmoc-β-ALA-4-CHLOO-D-D-Phe-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

72

Fmoc- (D-4APH (TBucbm)) 2-ئاھ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

73

FMOC-β-ALA-4A-4APH (TBucbm) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

74

FMOC-APH (L-HOM) -APH (L-HOR) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

75

FMOC-β-ALA-APH (L-HOR)--h

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

76

FMOC-Lys (IPR, BOC) - - (IPR, BOC) -o.h

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

77

FMOC-β-ALA-LYS (IPR, BOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

78

Fmoc-β-ALA-AEEA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

79

Fmoc-aib-aib-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

80

Fmoc-β-ALA-AIB-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

81

Fmoc-arg-oh

91000-69-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

82

H-arg (pbf) -oh

200115-86-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

83

Fmoc-d-arg-oh

130752-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

84

Hd-arg (pbf) -oh

20016-81-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

85

Fmoc-homoarg-oh.hcl

20817-4-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

86

H-HOMOARG (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

87

Fmoc-d-homoarg-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

88

HD-HOMOARG (PBF) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

89

Fmoc-asn-oh

71989-16-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

90

H-asn (TRT )-h

132388-58-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

91

Fmoc-asp-oh

119062---------------

≥98.0%

≤1.0%

≤8.0%

≤2.0%

92

H-asp (Otbu) -ھە

3057-74-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

93

Fmoc-cys-cys-oh

135248-89-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

94

H-CYS (TRT) -ھە

2799/7/7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

95

H-CYS (ACM) -oh.hcl

28798-28-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

96

Fmoc-gln-oh

71989-20-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

97

H-gln (TRT) -ھە-h

102747-84-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

98

Fmoc-glu-oh

121344-82-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

99

H-glu (OTBU) - -oh.h2o

2419-56-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

100

Fmoc-his-ha

116611-64--4-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

101

H-hera (TRT )-h

35146-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

102

Boc-his-feh

1779-52-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

103

Fmoc-lys-oh

105047-45-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

104

H-lys (boc) -oh

2418-95-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

105

H-lys (alclo) -oh

6298/9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

106

Fmoc-orn-ohn.hl

201046-57-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

107

H-orn (boc) -oh

13650-49-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

108

Fmoc-ser-oh

73724-45-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

109

H-SEAR (TBU)--oh

1882-58-7-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

110

H-ser (TRA) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

111

Fmoc-thr-oh.h2o

73731-37-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

112

H-thr (tbu)--h

4378-13-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

113

Fmoc-trp-oh

35737-15-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

114

H-trp (boc) -oh

146645-63-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

115

Fmoc-d-trp-oh

86123-11-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

116

HD-Trp (boc) -oh

2012-يىلى 20-11-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

117

FMOC-TYR-OH

92954-90-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

118

H-tyr (tbu)--h

1882-59-29-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

119

Fmoc-d-tyr-oh

11283-29-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

120

Hd-tyr (et) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

121

H-tyr (me)---hi.hcl

67423-44-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

122

FMOC-D-4APH (CBM) -ھە

324017-22-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

123

HD-4APH (TBucbm) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

124

Fmoc-lys (ipr) -ھە

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

125

H-lys (ipr, boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

ھەققىدە

تۆلەم

گېنتوگكىس ئېسىل مەھسۇلاتلارنى تەمىنلىگەن بولسا, يېتەرلىك ۋاقىتتا لازىم بولغان ۋاقىت ئىچىدە خېرىدارنىڭ سۈپىتى يۇقىرى بولغان بولسا, تۆلەم تەرتىپىگە يوللاشقا تاپشۇرۇپ بېرىش ۋە باھالاش تەييارلاش ئۈچۈن زۆرۈر ئاندىيا ۋە باھالاشلار بىلەن تەمىنلەيمىز.

ئىشلەپچىقىرىش

دورا مەھسۇلاتلىرىنىڭ پايچېكى راكېتالغا يېتىپ كەلگەنلىكى, خىمىيىلىك مەھسۇلاتلارنىڭ مەخپىيلىشىى 100ToNing + دەرىجىسى Kenter غا يېتىدۇ, ئىقتىدارى ياخشى سەپكە سەپلەنگەن.

تەتقىقات ۋە تەرەققىيات

ھەر يىلى R & D گۇرۇپپىسىنىڭ ئوخشىمىغان يېڭى مەھسۇلاتلىرىنى تەرەققىي قىلدۇرۇش پىلانىنىڭ پىلانى ئورنىتىلغان, نىشان توپلانغان ۋاقىتتا, كوماندىدىكى ھەر بىر ئەزا KpPian ۋە رىغبەتلەندۈرۈش سىياسىتىدە چىڭ تۇرۇشى كېرەك.


  • ئالدىنقىسى:
  • كېيىنكى:

  • ئۇچۇرىڭىزنى بۇ يەرگە يېزىڭ ۋە بىزگە ئەۋەتىڭ